Striving to Deliver Better Outcomes: Janssen to Showcase Commitment to.
The Pharma Data
AUGUST 31, 2021
S ites and Burden of Metastases and Long-Term Outcomes in TITAN Patients (moderated poster session) : Assessment of relationships between the number and location of metastases and oncological outcomes in 1,052 patients with metastatic castration-sensitive prostate cancer (mCSPC) enrolled in the TITAN trial (Abstract #MP24-08). About TAR-200.
52 
Let's personalize your content